Search
for
Sort by
Research 211–240 of 789
- New drugs under investigation for the treatment of alopecias
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Ritlecitinib: First Approval
- Alopecia Areata: Current Review
- Pharmacological Treatment of Alopecia
- A Novel Hope for Alopecia Totalis Patients: Case Report
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Emerging treatments in alopecia
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Hemp Seed-Derived Exosomes Protect Against Dihydrotestosterone-Induced Chicken Feather Growth Inhibition
- JAK inhibitors in dermatology: The promise of a new drug class
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK Inhibitors for Treatment of Alopecia Areata
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Surgical Approaches for Repigmenting Vitiligo 2.0
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A